Successes, Challenges, and Opportunities

The treatment of multiple sclerosis and our understanding of the disease have come a long way since the introduction of the first therapy for MS in 1993. Yet in spite of the successes, there are still challenges to overcome, and opportunities to improve our management of this condition.

2011 Crossfire Panel

Recorded live on November 8, 2011 at the studios of Detroit Public Television

In part 1 of this year’s program, Dr. Omar Khan and his panel of MS specialists will discuss the changing expectations of clinical trials, and updated information about fingolimod and natalizumab. In part 2, our experts will examine the data from clinical trials of some of the new oral agents in the pipeline; and debate a potential treatment stratification approach.

2011 Distinguished Faculty
Omar Khan

Omar Khan, MD, FRCP

Moderator
Edward J. Fox

Edward J. Fox, MD, PhD

Panelist
Bruce Cree

Bruce Cree, MD, PhD, MCR

Panelist
Fred D. Lublin

Fred D. Lublin, MD

Panelist

MS in the Crossfire 2010
The State of Disease-Modifying Therapies

Dr. Omar Khan and his panel of MS specialists will discuss the state of disease-modifying therapies as we enter the age of oral therapy.

Sponsored and supported by:

sponsors

This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Peer Health Communications.

This activity is supported by an educational grant from Teva Neuroscience.

Each part of the 2011 program is eligible for 1 AMA PRA Category 1 Credit™, for a total of 2.0 credits.